Progestogen News and Research

RSS

Study provides reassurance regarding the safety of using hormone therapy after age 65 years

After the Women's Health Initiative (WHI) in 2002, many women have resisted taking hormone therapy (HT), especially after age 65 years, because of fears of increased risks for various cancers and heart disease.

10 Apr 2024

Certain progestogens linked to higher brain tumor risk in women, study suggests

Study finds long-term use of specific progestogens increases the risk of benign brain tumors in women, while short-term use and other progestogens do not.

3 Apr 2024

Researchers identify increased brain tumor risk with specific contraceptive use

The intracranial meningioma risk associated with progestogen use.

28 Mar 2024

Long-term use of certain progestogen drugs may raise risk of intracranial meningioma

Prolonged use of certain progestogen hormone drugs is associated with an increased risk of developing a type of brain tumor known as an intracranial meningioma, finds a study from France published by The BMJ today.

27 Mar 2024

Association of estrogen-containing menopause hormonal therapy with COVID-19 mortality

Researchers evaluated coronavirus disease 2019 (COVID-19)-related mortality among perimenopausal women.

29 Feb 2024

Managing menopause: The 2023 toolkit for healthcare practitioners

The authors of the revised 2023 Toolkit extracted key recommendations from professional guidelines and positions as well as consensus statements on menopause and related conditions that have emerged since 2014.

1 Nov 2023

Is menopausal hormone therapy associated with non-alcoholic fatty liver disease?

The effects of menopausal hormone therapy on non-alcoholic fatty liver disease.

21 Sep 2023

World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

In a recent review published in Cell, a group of authors delved into the complexities of menopause, assessed its global impacts on health, and evaluated the effectiveness and safety of current treatments, emphasizing the importance of further research.

6 Sep 2023

Menopausal hormone therapy associated with increased rate of dementia and Alzheimer's disease

Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer's disease, suggests a large Danish study published by The BMJ today.

3 Jul 2023

Use of menopausal hormone therapy associated with increased rate of dementia and Alzheimer's

Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer's disease, suggests a large Danish study published by The BMJ today.

28 Jun 2023

Women's use of contraceptive pills linked to greater risk of depression

Women who used combined contraceptive pills were at greater risk of developing depression than women who did not, according to a new study from Uppsala University. Contraceptive pills increased women's risk by 73 per cent during the first two years of use.

12 Jun 2023

Use of hormone therapies linked with bone protection in postmenopausal women

As the population continues to age, there is greater focus on bone health and minimizing fractures to maintain mobility.

8 May 2023

Hormonal contraceptives and breast cancer: what's the risk?

The current study, reported in the PLOS Medicine journal, explored breast cancer risk linked to the current or past use of hormonal contraception during the reproductive period in women.

26 Mar 2023

Study measures arterial stiffness in women from wide age range

A study conducted at the University of Jyväskylä in the Faculty of Sport and Health Sciences measured arterial stiffness in women from wide age range.

10 Dec 2021

Study finds an increase in unplanned pregnancies during the first lockdown

There were nearly twice as many unplanned pregnancies during the first lockdown compared to before, finds a major study led by researchers from UCL and University College London Hospital.

22 Oct 2021

Menopausal Hormone Therapy and Dementia

News-Medical speaks to Dr. Yana Vinogradova about her latest research into menopausal hormone therapy (MHT) and its unassociated risk to dementia.

6 Oct 2021

Study finds no link between menopausal hormone therapy and increased risk of dementia

Use of menopausal hormone therapy (MHT, also known as hormone replacement therapy, HRT) is not associated with an increased risk of developing dementia, regardless of hormone type, dose, or duration, concludes a large UK study published by The BMJ.

30 Sep 2021

Lack of contraception data could conceal pandemic’s impact on women’s reproductive health

Limited data on the uptake of contraception prior to and during crises such as the Covid-19 pandemic could mean unforeseen issues for sexual and reproductive health services, research from the University of Warwick concludes.

17 Jun 2021

Researchers reveal several risk factors that elevate stroke risk among women

Stroke disproportionately affects more women than men. It is the third leading cause of death in women in the United States, is a leading cause of disability and affects 55,000 more women than men each year.

8 Feb 2018

Menopausal hormone therapy may protect women from stress' negative effects on memory

Menopausal hormone therapy may shield women from stress' negative effects on some types of memory, according to a small-scale study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

2 Nov 2017